Science Explorer Back to mapMap

Most cited papers from Bio Products Laboratory (United Kingdom)

What are the most cited papers from Bio Products Laboratory (United Kingdom)?

The most cited paper from Bio Products Laboratory (United Kingdom) is "Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins" (Jeffrey L. Rossio, M. T. Esser, K. Suryanarayana et al., 1998), with 420 citations. Next come "Guidance on Good Cell Culture Practice" (365) and "Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease" (180).

Showing 50 of 59 papers. Every paper with more than 20 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins Jeffrey L. Rossio, M. T. Esser, K. Suryanarayana et al. · Journal of Virology Open access Oct 1998 420
2 Guidance on Good Cell Culture Practice Sandra Coecke, Michael Balls, Gerard Bowe et al. · Alternatives to Laboratory Animals Jun 2005 365
3 Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease Edward G. D. Tuddenham, R. S. Lane, Frances Rotblat et al. · British Journal of Haematology Oct 1982 180
4 NON-A, NON-B HEPATITIS FROM INTRAVENOUS IMMUNOGLOBULIN R. S. Lane · The Lancet Oct 1983 112
5 Virus inactivation by high intensity broad spectrum pulsed light Peter L. Roberts, Andrew G. Hope · Journal of Virological Methods 19 May 2003 111
6 Production of human albumin solution: a continually developing colloid Paul Matejtschuk, C. H. Dash, E. Gascoigne · British Journal of Anaesthesia Open access Dec 2000 102
7 Characterization of flow intensity in continuous centrifuges for the development of laboratory mimics M. Boychyn, Sung-Sam Yim, P. Ayazi Shamlou et al. · Chemical Engineering Science Aug 2001 93
8 Triazine-dye affinity chromatography Tony Atkinson, Peter Hammond, ROY D. HARTWELL et al. · Biochemical Society Transactions Aug 1981 90
9 Performance prediction of industrial centrifuges using scale-down models M. Boychyn, Sung-Sam Yim, Mark Bulmer et al. · Bioprocess and Biosystems Engineering 18 Oct 2003 85
10 A review on biocide reduced susceptibility due to plasmid‐borne antiseptic‐resistant genes—special notes on pharmaceutical environmental isolates Rajendran Vijayakumar, Tim Sandle · Journal of Applied Microbiology 2 Oct 2018 77
11 Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii — A first report from the Kingdom of Saudi Arabia Rajendran Vijayakumar, Tim Sandle, Mohammad Saleh Al-Aboody et al. · Journal of Infection and Public Health Open access 12 Jun 2018 71
12 Clearance of Rh D-positive red cells with monoclonal anti-D Amanda R Thomson, Miguel Alejandro Saquimux Contreras, P. Teesdale et al. · The Lancet Nov 1990 68
13 Production and Therapeutic Use of a Factor XI Concentrate from Plasma Paula H. B. Bolton‐Maggs, Richard T. Wensley, PB Kernoff et al. · Thrombosis and Haemostasis 1992 67
14 Graphene oxide incorporated collagen–fibrin biofilm as a wound dressing material R. Deepachitra, V. Ramnath, Thotapalli Parvathaleswara Sastry · RSC Advances 2014 66
15 Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin Patrick Garland, Matthew J Morton, William Haskins et al. · Brain Communications Open access 2020 63
16 Fabrication of collagen scaffolds impregnated with sago starch capped silver nanoparticles suitable for biomedical applications and their physicochemical studies Abhishek Mandal, Abhishek Mandal, Santhanam Sekar et al. · Physical Chemistry Chemical Physics 2014 57
17 Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII Peter L. Roberts · Biologicals 4 Aug 2008 56
18 Synthesis, characterization and evaluation of collagen scaffolds crosslinked with aminosilane functionalized silver nanoparticles: in vitro and in vivo studies Abhishek Mandal, Santhanam Sekar, Natarajan Chandrasekaran et al. · Journal of Materials Chemistry B 2015 52
19 Cell-surface markers on haemopoietic precursors. Reagents for the isolation and analysis of progenitor cell subpopulations Suzanne M. Watt, David J. Gilmore, John M. Davis et al. · Molecular and Cellular Probes Dec 1987 52
20 Laboratory scaledown of protein purification processes involving fractional precipitation and centrifugal recovery M. Boychyn, W. M. Doyle, Mark Bulmer et al. · Biotechnology and Bioengineering 5 Jul 2000 51
21 Isolation of monocytes from human peripheral blood using immuno‐affinity expanded‐bed adsorption L. B. Ujam, Robert H. Clemmitt, Susan A. Clarke et al. · Biotechnology and Bioengineering 20 Jun 2003 45
22 Vibrational spectroscopic investigation on interaction of sago starch capped silver nanoparticles with collagen: a comparative physicochemical study using FT-IR and FT-Raman techniques Abhishek Mandal, Santhanam Sekar, Natarajan Chandrasekaran et al. · RSC Advances 2015 45
23 Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers Jean Goodrick, Belinda M. Kumpel, DH Pamphilon et al. · Clinical & Experimental Immunology Open access Oct 1994 44
24 Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers Nathan Roth, Herbert O. Dichtelmüller, Fabrizio Fabbrizzi et al. · Transfusion Open access 19 Aug 2020 43
25 Virus inactivation by protein denaturants used in affinity chromatography Peter L. Roberts, David Hugh Lloyd · Biologicals 25 May 2007 42
26 Effects of Handling and Storage of Blood on the Stability of Hepatitis C Virus RNA: Implications for NAT Testing in Transfusion Practice Paul R. Grant, Alan D. Kitchen, Jeffrey A.J. Barbara et al. · Vox Sanguinis Apr 2000 41
27 Bone formation in a carbonate-substituted hydroxyapatite implant is inhibited by zoledronate Gavin M. Spence, Stephen Phillips, Charlie R. Campion et al. · Journal of Bone and Joint Surgery - British Volume Open access 30 Nov 2008 41
28 Large-scale preparation and biochemical characterization of a new high purity factor IX concentrate prepared by metal chelate affinity chromatography Peter A. Feldman, P I Bradbury, John D. Williams et al. · Blood Coagulation & Fibrinolysis Dec 1994 41
29 Scale‐down of continuous filtration for rapid bioprocess design: Recovery and dewatering of protein precipitate suspensions Tommy Sean Reynolds, M. Boychyn, T. Sanderson et al. · Biotechnology and Bioengineering 4 Jun 2003 39
30 Resistance of Vaccinia Virus to Inactivation by Solvent/Detergent Treatment of Blood Products Peter L. Roberts · Biologicals Mar 2000 39
31 Activation of a procollagenase by low-molecular-weight angiogenesis factor Jacqueline B. Weiss, Christopher R. Hill, R. J. Davis et al. · Bioscience Reports Feb 1983 38
32 ‘Gimme shelter’ Finola Kerrigan, Gretchen Larsen, Sorcha Hanratty et al. · Marketing Theory Open access 25 Feb 2014 36
33 Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C‐reactive protein, for clinical use Mark B. Pepys, J. Ruth Gallimore, Joanne Lloyd et al. · Journal of Immunological Methods Open access 31 Jul 2012 36
34 Virus Safety of Plasma Products Paula Roberts · Reviews in Medical Virology Mar 1996 35
35 Severely Heated Therapeutic Factor VIII Concentrate of High Specific Activity L. Winkelmana, N. E. Owena, David R. Evans et al. · Vox Sanguinis Sep 1989 35
36 Liquid Flow and Mixing in Concentric Tube Air-Lift Reactors José C. Merchuk, Narendra Ladwa, Angus Cameron et al. · Journal of Chemical Technology & Biotechnology Jun 1996 33
37 Neurofilament light predicts neurological outcome after subarachnoid haemorrhage Patrick Garland, Matt Morton, Ardalan H Zolnourian et al. · Brain Open access 22 Dec 2020 32
38 Efficacy, safety and pharmacokinetics of a new high‐purity factor X concentrate in subjects with hereditary factor X deficiency Steve K. Austin, Kaan Kavaklı, M. Norton et al. · Haemophilia Open access 8 Mar 2016 31
39 In vitro fungicidal activity of biocides against pharmaceutical environmental fungal isolates Tim Sandle, Rajendran Vijayakumar, Mohammed Saleh Al Aboody et al. · Journal of Applied Microbiology 23 Aug 2014 31
40 Experience of a new high‐purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgery Miguel Antonio Escobar, G. Auerswald, Steve K. Austin et al. · Haemophilia 24 May 2016 29
41 Fingerprinting of glycans as their 2‐aminoacridone derivatives by capillary electrophoresis and laserinduced fluorescence Gary Harland, George N. Okafo, Paul Matejtschuk et al. · Electrophoresis 1996 29
42 Removal and Inactivation of Enveloped and Non‐Enveloped Viruses during the Purification of a High‐Purity Factor IX by Metal Chelate Affinity Chromatography Peter L. Roberts, Chris P. Walker, Peter A. Feldman · Vox Sanguinis Jun 1994 26
43 Virus elimination during the purification of monoclonal antibodies by column chromatography and additional steps Peter L. Roberts · Biotechnology Progress 2 Sep 2014 24
44 Risk factors for the early acquisition of human herpesvirus 6 and human herpesvirus 7 infections in children Bruce Perrin Lanphear, Caroline Breese Hall, Jodi B. Black et al. · The Pediatric Infectious Disease Journal Sep 1998 24
45 Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita U. Tayal, Janet Burton, C. H. Dash et al. · Clinical Immunology 11 Oct 2008 24
46 Comparison of the Inactivation of Canine and Bovine Parvovirus by Freeze-drying and Dry-heat Treatment in Two High Purity Factor VIII Concentrates Peter L. Roberts, Helena Hart · Biologicals Sep 2000 23
47 Nucleic acid technology (NAT) testing and the transfusion service: a rationale for the implementation of minipool testing F LANAGAN, S NAPE · Transfusion Medicine Mar 1998 23
48 Virological safety of the purified factor IX concentrate, Replenine Peter B. Roberts · Haemophilia 1995 23
49 Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals Tim Sandle, Madhu Raju Saghee · Journal of Commercial Biotechnology 2 Aug 2011 23
50 A cross‐over pharmacokinetic and thrombogenicity study of a prothrombin complex concentrate and a purified factor IX concentrate D P Thomas, K. K. Hampton, H. Dasani et al. · British Journal of Haematology Aug 1994 23

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.